Microbiota transplant to control inflammation in a patient with NLRC4 gain-of-function–induced disease 🔗 Access full article via Journal of Allergy and Clinical ImmunologyShare:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
